REVIEW - ADJUVANT HORMONOTHERAPY FOR BREAST-CANCER

被引：5
|
作者：
GREM, JL [1 ]
CARBONE, PP [1 ]
机构：
[1] UNIV WISCONSIN,DEPT MED,MADISON,WI 53706
来源：
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1986年 / 22卷 / 03期
关键词：
D O I：
10.1016/0277-5379(86)90385-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：235 / 239
页数：5
相关论文
共 50 条
  • [1] HORMONOTHERAPY OF METASTATIC BREAST-CANCER - A REVIEW
    NAMER, M
    BULLETIN DU CANCER, 1989, 76 (01) : 65 - 73
  • [2] HORMONOTHERAPY OF BREAST-CANCER
    MOISEYENKO, VM
    SEMIGLAZOV, VF
    VOPROSY ONKOLOGII, 1984, 30 (11) : 3 - 9
  • [3] CONTROVERSIES IN THE USE OF ADJUVANT CHEMOTHERAPY, HORMONOTHERAPY AND RADIOTHERAPY FOR BREAST-CANCER
    DONEGAN, WL
    CANADIAN JOURNAL OF SURGERY, 1992, 35 (04) : 371 - 377
  • [4] HORMONOTHERAPY OF BREAST-CANCER - TAMOXIFEN
    JOLIVET, J
    LEGAULTPOISSON, S
    BAND, P
    UNION MEDICALE DU CANADA, 1978, 107 (10): : 964 - 965
  • [5] HORMONOTHERAPY OF METASTATIC BREAST-CANCER
    MERKLE, E
    BAHR, I
    FUCHS, U
    EUROPEAN JOURNAL OF CANCER, 1990, 26 (02) : 166 - 166
  • [6] PROGRESS AND CONTROVERSIES IN HORMONOTHERAPY OF BREAST-CANCER
    SAMONIS, G
    JOURNAL OF CHEMOTHERAPY, 1993, 5 : 692 - 693
  • [7] REEVALUATION OF THE INDICATIONS OF ADJUVANT HORMONOTHERAPY IN HIGH-RISK PRIMARY BREAST-CANCER PATIENTS
    MARTIN, PM
    ROMAIN, S
    SPYRATOS, F
    SPITALIER, JM
    AYME, Y
    BRANDONE, H
    BRESSAC, C
    HANS, D
    JACQUEMIER, J
    HACENE, K
    BRUNET, M
    AMALRIC, R
    BULLETIN DU CANCER, 1991, 78 (08) : 709 - 723
  • [8] STUDY OF PROGNOSTIC FACTORS AFTER ADJUVANT CHEMO-HORMONOTHERAPY IN OPERABLE BREAST-CANCER
    CHAUVIN, F
    CLAVEL, M
    MAYER, M
    BULLETIN DU CANCER, 1986, 73 (04) : 461 - 461
  • [9] CEA ASSOCIATED WITH HORMONOTHERAPY IN METASTATIC BREAST-CANCER
    KREBS, BP
    LUPO, R
    NAMER, M
    BOUBLIL, JL
    SCHNEIDER, M
    LALANNE, CM
    BULLETIN DU CANCER, 1976, 63 (04) : 485 - 488
  • [10] ESTROGEN ANTAGONISTS AND INHIBITORS IN THE HORMONOTHERAPY OF BREAST-CANCER
    DRZHAK, VI
    VOPROSY ONKOLOGII, 1989, 35 (07) : 771 - 778
12345